| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2004;110:3003-3010.)
© 2004 American Heart Association, Inc.
Arrhythmia/Electrophysiology |
From the Division of Cardiology (L.L., C.V., D.B., V.J., Z.E., T.D., D.D., R.B., H.C.) and the Department of Radiology and Radiological Science (M.M., D.K.), The Johns Hopkins Hospital, Baltimore, Md, and the Department of Medicine-Cardiology, University of Bonn, Bonn, Germany (L.L., B.L.).
Correspondence to Mahadevappa Mahesh, MS, PhD, The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University, 601 N Caroline St, Baltimore, MD 21287-0856. E-mail mmahesh{at}jhmi.edu
Received March 23, 2004; revision received June 16, 2004; accepted June 17, 2004.
Background The purpose of this study was to determine the radiation exposure during catheter ablation of atrial fibrillation (AF) using the pulmonary vein (PV) approach.
Methods and Results The study included 15 patients with AF and 5 patients each with atrial flutter and atrioventricular nodal reentrant tachycardia (AVNRT) who underwent fluoroscopically guided procedures on a biplane x-ray system operated at a low-frame pulsed fluoroscopy (7.5 frames per second). Radiation exposure was measured directly with 50 to 60 thermoluminescent dosimeters (TLDs). Peak skin doses (PSDs), effective radiation doses, and risk of fatal malignancies were all computed. Mean fluoroscopy durations for AF procedures were 67.8±21 minutes in the right anterior oblique (RAO) and 61.9±16.6 minutes in the left anterior oblique (LAO) projection, significantly different from that required for atrial flutter and AVNRT. The mean PSDs measured with the TLDs were 1.0±0.5 Gy in the RAO and 1.5±0.4 Gy in the LAO projection. The lifetime risk of excess fatal malignancies normalized to 60 minutes of fluoroscopy was 0.07% for women and 0.1% for men.
Conclusions The relatively small amounts of the patients radiation exposure in this study, despite the prolonged fluoroscopy durations, can be attributed to the use of very-low-frame pulsed fluoroscopy, the avoidance of magnification, and optimal adjustments of the fluoroscopy exposure rates. The resulting lifetime risk of fatal malignancy is within the range previously reported for standard supraventricular arrhythmias.
Key Words: catheter ablation radiography radiation
This article has been cited by other articles:
![]() |
J. D. Ferguson, A. Helms, J. M. Mangrum, S. Mahapatra, P. Mason, K. Bilchick, G. McDaniel, D. Wiggins, and J. P. DiMarco Catheter Ablation of Atrial Fibrillation Without Fluoroscopy Using Intracardiac Echocardiography and Electroanatomic Mapping Circ Arrhythm Electrophysiol, December 1, 2009; 2(6): 611 - 619. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Aliot, W. G. Stevenson, J. M. Almendral-Garrote, F. Bogun, C. H. Calkins, E. Delacretaz, P. D. Bella, G. Hindricks, P. Jais, M. E. Josephson, et al. EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: Developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA) Europace, June 1, 2009; 11(6): 771 - 817. [Full Text] [PDF] |
||||
![]() |
T. Moritake, Y. Matsumaru, T. Takigawa, K. Nishizawa, A. Matsumura, and K. Tsuboi Dose Measurement on Both Patients and Operators during Neurointerventional Procedures Using Photoluminescence Glass Dosimeters AJNR Am. J. Neuroradiol., November 1, 2008; 29(10): 1910 - 1917. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. Mettler Jr, W. Huda, T. T. Yoshizumi, and M. Mahesh Effective Doses in Radiology and Diagnostic Nuclear Medicine: A Catalog Radiology, July 1, 2008; 248(1): 254 - 263. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ector, O. Dragusin, B. Adriaenssens, W. Huybrechts, R. Willems, H. Ector, and H. Heidbuchel Obesity Is a Major Determinant of Radiation Dose in Patients Undergoing Pulmonary Vein Isolation for Atrial Fibrillation J. Am. Coll. Cardiol., July 17, 2007; 50(3): 234 - 242. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Handke, G. Heinrichs, U. Moser, F. Hirt, F. Margadant, F. Gattiker, C. Bode, and A. Geibel Transesophageal Real-Time Three-Dimensional Echocardiography: Methods and Initial In Vitro and Human In Vivo Studies J. Am. Coll. Cardiol., November 21, 2006; 48(10): 2070 - 2076. [Abstract] [Full Text] [PDF] |
||||
![]() |
N Theocharopoulos, J Damilakis, K Perisinakis, E Manios, P Vardas, and N Gourtsoyiannis Occupational exposure in the electrophysiology laboratory: quantifying and minimizing radiation burden Br. J. Radiol., August 1, 2006; 79(944): 644 - 651. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. P. Efstathopoulos, D. G. Katritsis, S. Kottou, N. Kalivas, E. Tzanalaridou, E. Giazitzoglou, S. Korovesis, and K. Faulkner Patient and staff radiation dosimetry during cardiac electrophysiology studies and catheter ablation procedures: a comprehensive analysis Europace, June 1, 2006; 8(6): 443 - 448. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Scheinman and E. Keung The year in clinical electrophysiology J. Am. Coll. Cardiol., March 1, 2005; 45(5): 790 - 795. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |